Clinical Trial Update: Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/2 study evaluating the Sm-TSP-2 vaccine for schistosomiasis in healthy Ugandan adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis

Drugs mentioned

• Sm-TSP-2 vaccine (Schistosoma mansoni tetraspanin-2 (TSP-2) antigen)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Schistosomiasis, Schistosoma Mansoni | Phase 1, Phase 2 | Status: COMPLETED